Poalen Tablets (Sodium Alendronate Trihydrate)
Sodium Alendronate Trihydrate 91.37mg
Tablet · Prescription medication
Boinex Co., Ltd.
MFDS item code 201901509 · Approved 2019.03.12
This product's status changed to Expired on 2024.03.12. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of osteoporosis in postmenopausal women and men
This medication is used for the treatment of osteoporosis in postmenopausal women and men.
Take 70 mg of alendronic acid once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see Precautions). Other beverages or food, including mineral water and barley tea, and medicines may reduce the absorption of this medicine (see Interactions). Taking food within 30 minutes after taking this medicine or at the same time may reduce its absorption into the body and decrease its effect. Take this medicine as soon as you get up in the morning and swallow it with plenty of water (170 ∼ 230 mL) to ensure that it reaches the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after your first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). Patients whose dietary intake of calcium and vitamin D is insufficient should take supplements (see Precautions). The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. Patients at low risk of fracture should be considered for discontinuation after taking this medicine for 3 ∼ 5 years. Patients who discontinue treatment should be reassessed regularly for fracture risk. If you forget to take a dose on the scheduled day, take 70 mg the next morning, then resume taking it on the originally scheduled day and continue once weekly thereafter. Do not take 2 tablets on the same day.
This medication may cause stomach irritation, so patients with upper gastrointestinal disorders such as gastritis, esophagitis, or esophageal ulcers should take caution while using it. After taking this medication, inflammation or ulcers may occur in the esophagus, and in rare cases, severe problems such as esophageal obstruction or perforation may occur; if symptoms appear, the patient should cease taking the medication immediately and consult a physician. When taking this medication, it should be taken with a sufficient amount of water, and the patient should avoid lying down for at least 30 minutes after taking it. Failure to follow the proper administration methods increases the risk of esophageal irritation. Patients with esophageal motility disorders, those who cannot sit or stand upright, patients allergic to this medication or its components, patients with hypocalcemia, severe renal failure, pregnant or nursing women, and individuals with congenital lactose intolerance should not take this medication. While taking this medication, reactions such as abdominal pain, indigestion, nausea, constipation, diarrhea, acid reflux, esophageal ulcers, muscle or joint pain, headaches, dizziness, and skin rashes may occur; any unusual symptoms should be reported to a physician. Especially with long-term use, rare occurrences of stress fractures in bones may arise, so if pain persists, an examination is necessary. This medication is necessary to supplement calcium or vitamin D if they are deficient, and when taking calcium supplements or antacids together, a minimum interval of 30 minutes should be maintained to prevent impediment to absorption of the medication. Pregnant or nursing women should not take this medication, and the safety and efficacy for children and adolescents under 18 years old have not been established. Elderly patients can also take this medication, but caution is necessary as some elderly may be more sensitive to the drug. In case of overdose, symptoms such as hypocalcemia and gastrointestinal disturbances may occur, and vomiting should not be induced; the patient should be kept in an upright position. This medication should be stored out of the reach of children, and care should be taken to avoid transferring it to another container to prevent accidents or degradation of quality.
esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, gastroesophageal reflux, vomiting, dysphagia, abdominal distension, gastritis, musculoskeletal (bone, muscle, or joint) pain, muscle cramps, headache, dizziness, taste disorder, rash, erythema, anastomotic ulcer, urticaria, angioedema, myalgia, fatigue, asthenia, fever, symptoms of hypocalcemia, peripheral edema, oropharyngeal ulcer, gastric ulcer, duodenal ulcer, focal jawbone necrosis, joint swelling, low-energy fracture of the femoral neck, itching, hair loss, mucocutaneous syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is advisable to keep it in a cool place between 15 to 30 degrees Celsius. Proper storage can help maintain the effectiveness of the medication over time.
White oval-shaped tablet
4 tablets (4 tablets/PTP packaging (AluAlu)x1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sodium Alendronate Trihydrate 91.37mg
Tablet · Prescription medication
Boinex Co., Ltd.

Sodium Alendronate Hydrate 91.37mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Sodium Alendronate 91.37mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Sodium Alendronate Hydrate 91.37mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Sodium Alendronate 91.37mg
Tablet · Prescription medication
(Co., Ltd.) Jungkundang

Sodium Alendronate Hydrate 91.37mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Sodium Alendronate Hydrate 91.37mg
Tablet · Prescription medication
Korea PMG Pharmaceutical Co., Ltd.

Sodium Alendronate Hydrate 91.37mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.